High-dose methylprednisolone in nonintubated patients with severe COVID-19 pneumonia
Papamanoli A, et al.〔Eur J Clin Invest. 2021 Feb;51(2):e13458〕（査読済み）
Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children
Ouldali N, et al.〔JAMA. 2021 Mar 2;325(9):855-864〕（査読済み）
Corticosteroid treatment has no effect on hospital mortality in COVID-19 patients
Albani F, et al.〔Sci Rep. 2021 Jan 13;11(1):1015〕（査読済み）
High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response
López Zúñiga MÁ, et al.〔PLoS One. 2021 Jan 28;16(1):e0243964〕（査読前）
Timing of corticosteroids impacts mortality in hospitalized COVID-19 patients
Bahl A, et al.〔Intern Emerg Med. 2021 Feb 5:1-11〕（査読済み）
Comparison of Associations between Glucocorticoids Treatment and Mortality in COVID-19 Patients and SARS Patients: A Systematic Review and Meta-Analysis
Li J, et al.〔Shock. 2021 Feb 3〕（査読済み）
Dexamethasone in Hospitalized Patients with Covid-19